{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:16:46Z","timestamp":1792192606274,"version":"4.4.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/wnf.0b013e318294799a","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T11:59:00Z","timestamp":1371556740000},"page":"131-132","source":"Crossref","is-referenced-by-count":14,"title":["Neuroleptic Malignant Syndrome Induced by Lamotrigine"],"prefix":"10.1097","volume":"36","author":[{"given":"Masamichi","family":"Ishioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yasui-Furukori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210203","first-page":"79","article-title":"the neuroleptic malignant syndrome.","volume":"41","author":"Caroff","year":"1980","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.58.3.271","article-title":"Neuroleptic malignant syndrome.","volume":"58","author":"Buckley","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"18","key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"E834","DOI":"10.1503\/cmaj.091442","article-title":"Neuroleptic malignant syndrome: a neuroimmunologic hypothesis.","volume":"182","author":"Anglin","year":"2010","journal-title":"CMAJ"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome.","volume":"164","author":"Strawn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/ajp.143.10.1227","article-title":"Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.","volume":"143","author":"Pope","year":"1986","journal-title":"Am J Psychiatry"},{"issue":"6","key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00023210-200923060-00003","article-title":"Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.","volume":"23","author":"Trollor","year":"2009","journal-title":"CNS Drugs"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1684\/epd.2007.0144","article-title":"Treatment of pediatric epilepsy: European expert opinion 2007.","volume":"9","author":"Wheless","year":"2007","journal-title":"Epileptic Disord"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.pnpbp.2008.03.004","article-title":"The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression.","volume":"32","author":"Muck-Seler","year":"2008","journal-title":"Neuropsychopharmacol Biol Psychiatry"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S0012162200001055","article-title":"Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsy.","volume":"42","author":"Samson-Fang","year":"2000","journal-title":"Dev Med Child Neurol"},{"issue":"15","key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2146\/ajhp090243","article-title":"Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient.","volume":"67","author":"Patel","year":"2010","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.WNF.0000240941.13876.5E","article-title":"Neuroleptic malignant syndrome from aripiprazole in an agitated pediatric patient.","volume":"30","author":"Palakurthi","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1353-8020(02)00035-4","article-title":"Neuroleptic malignant syndrome-like, or-dopaminergic malignant syndrome-due to levodopa therapy withdrawal. Clinical features in 11 patients.","volume":"9","author":"Serrano-Duenas","year":"2003","journal-title":"Parkinson Relat Disord"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e318294799a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T14:39:45Z","timestamp":1715524785000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201307000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e318294799a","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}